Multiple sclerosis and Oesophageal carcinoma
Oesophageal carcinoma is found among people with Multiple sclerosis, especially for people who are male, 50-59 old.
The study analyzes which people have Oesophageal carcinoma with Multiple sclerosis. It is created by eHealthMe based on reports of 175 people who have Multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
175 people who have Multiple Sclerosis and Oesophageal Carcinoma are studied.
What is Multiple sclerosis?
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 2,068 drugs and 1,284 conditions by eHealthMe.
What is Oesophageal carcinoma?
Oesophageal carcinoma (cancer tumour of oesophagus) is found to be associated with 757 drugs and 388 conditions by eHealthMe.
Number of Oesophageal carcinoma in Multiple sclerosis reports submitted per year:
Gender of people who have Multiple sclerosis and experienced Oesophageal carcinoma *:
Age of people who have Multiple sclerosis and experienced Oesophageal carcinoma *:
Common co-existing conditions for these people *:
Common drugs taken by these people *:
Common symptoms for these people *:
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Oesophageal carcinoma?Check whether Oesophageal carcinoma is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
- Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .
Treatments, associated drugs and conditions:
COVID vaccines that are related to Oesophageal carcinoma:
- Oesophageal carcinoma in Moderna COVID Vaccine
- Oesophageal carcinoma in Pfizer BioNTech Covid Vaccine
- Oesophageal carcinoma in Johnson and Johnson Covid Vaccine
Common drugs associated with Oesophageal carcinoma:
- Zantac: 18,962 reports
- Ranitidine: 8,936 reports
- Nexium: 245 reports
- Omeprazole: 199 reports
- Prednisolone: 172 reports
- Methotrexate: 170 reports
- Prednisone: 162 reports
- Humira: 148 reports
- Clozaril: 136 reports
- Enbrel: 125 reports
All the drugs that are associated with Oesophageal carcinoma:
- Oesophageal carcinoma (757 drugs)
Common conditions associated with Oesophageal carcinoma:
- Indigestion: 15,098 reports
- Gastric ulcer: 1,508 reports
- Rheumatoid arthritis: 271 reports
- Multiple sclerosis: 175 reports
- High blood pressure: 171 reports
- Osteoporosis: 156 reports
All the conditions that are associated with Oesophageal carcinoma:
- Oesophageal carcinoma (388 conditions)
How the study uses the data?
The study is based on Oesophageal carcinoma and Multiple sclerosis, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Sodium Bicarbonate and Topamax drug interaction - now
- Norvasc vs. Losartan Potassium - 2 seconds ago
- Sumatriptan Succinate and Constipation - 2 seconds ago
- Veramyst and Vitamin D drug interaction - 10 seconds ago
- Hizentra and Ofev drug interaction - 14 seconds ago
- Adriamycin Rdf and Septic Shock - 20 seconds ago
- Skin Hypertrophy and pfizer biontech covid vaccine - 21 seconds ago
- Dutasteride and Type 1 Diabetes - 23 seconds ago
- Atazanavir Sulfate and Atrioventricular Block - 27 seconds ago
- Vaginal Discharge in Lamotrigine, how severe and when it was recovered? - 29 seconds ago